Jump Financial’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,529
Closed -$154K 2029
2025
Q3
$154K Buy
+15,529
New +$162K ﹤0.01% 1679
2024
Q4
Sell
-63,864
Closed -$711K 1742
2024
Q3
$711K Buy
+63,864
New +$704K 0.01% 961
2023
Q3
Sell
-10,339
Closed -$134K 1942
2023
Q2
$134K Sell
10,339
-96,402
-90% -$1.1M ﹤0.01% 1605
2023
Q1
$1.05M Buy
+106,741
New +$1.14M 0.04% 578
2022
Q2
Sell
-28,300
Closed -$307K 1712
2022
Q1
$307K Sell
28,300
-98,036
-78% -$1.19M 0.01% 1059
2021
Q4
$1.78M Sell
126,336
-27,347
-18% -$450K 0.11% 232
2021
Q3
$2.95M Buy
153,683
+33,111
+27% +$440K 0.21% 75
2021
Q2
$1.19M Buy
+120,572
New +$1.1M 0.11% 236
2020
Q4
Sell
-154,918
Closed -$669K 996
2020
Q3
$669K Buy
+154,918
New +$1.11M 0.13% 239

Other funds holding DVAX

Jump Financial's DVAX Position: Q4 2025 in Review

Jump Financial sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 15,529 shares — an estimated $154K sold.

Jump Financial first reported a position in DVAX in Q3 2020 and held it in 9 quarters. The position peaked at $2.95M in Q3 2021. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Jump Financial reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Jump Financial sold 15,529 Dynavax Technologies shares in Q4 2025, an estimated $154K.
  • Jump Financial first reported a position in Dynavax Technologies in Q3 2020 and held it in 9 quarters.
  • Jump Financial's Dynavax Technologies position peaked at $2.95M in Q3 2021.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Jump Financial's 13F filing for Q4 2025, filed 17 Feb 2026.